Adocia/ FR0011184241 /
6/7/2024 5:35:09 PM | Chg. +0.010 | Volume | Bid3:01:16 AM | Ask3:01:16 AM | High | Low |
---|---|---|---|---|---|---|
8.560EUR | +0.12% | 58,745 Turnover: 499,575.800 |
8.550Bid Size: 90 | 8.630Ask Size: 580 | 8.640 | 8.380 |
GlobeNewswire
3/28/2022
Adocia strengthens its cash position by 19 million euros following a real estate transaction
GlobeNewswire
10/14/2021
Adocia’s Partner Tonghua Dongbao Receives Clearance to Start Ultra-Rapid Insulin BioChaperone® Lispr...
GlobeNewswire
9/10/2021
Adocia to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
GlobeNewswire
6/29/2021
Adocia Initiates BC LisPram Phase 1 Clinical Trial in Pump for People with Type 1 Diabetes
GlobeNewswire
6/15/2021
ADOCIA Announces M1Pram Clinical Data Presentation at the American Diabetes Association® 81ˢᵗ Scient...
GlobeNewswire
5/26/2021
Adocia Expands Clinical Development to Obesity with Patent Applications on Short-Acting Multihormona...
GlobeNewswire
12/11/2018
Biopharmaceutical Drug Delivery Device Technology - Global Markets to 2023: Trends & Developments
GlobeNewswire
9/11/2014
Wolters Kluwer Included in Dow Jones Sustainability Indices for Eighth Consecutive Year
GlobeNewswire
8/26/2014
Wolters Kluwer Legal & Regulatory Solutions Announces Gregory Samios as Wolters Kluwer Law & Busines...
GlobeNewswire
7/22/2014
Wolters Kluwer Legal & Regulatory to Acquire LexisNexis Legal Business in Poland and Divest Canadian...
GlobeNewswire
4/23/2014
Wolters Kluwer Shareholders Approve Dividend and New Supervisory Board Member Appointment
GlobeNewswire
4/7/2014
Wolters Kluwer Completes Acquisition of Remaining 62% of Third Coast Holdings